Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ocular Genomics Institute, |
RCV001376320 | SCV001573424 | pathogenic | Retinitis pigmentosa 66 | 2021-04-08 | criteria provided, single submitter | research | The RBP3 c.1162C>T variant was identified in an individual with retinitis pigmentosa with a presumed recessive inheritance pattern. Through a review of available evidence we were able to apply the following criteria: PM2, PVS1, PM3. Based on this evidence we have classified this variant as Pathogenic. |
Labcorp Genetics |
RCV003558771 | SCV004294359 | pathogenic | not provided | 2023-07-19 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 978973). This premature translational stop signal has been observed in individual(s) with retinitis pigmentosa (PMID: 23105016). This variant is present in population databases (rs782245537, gnomAD 0.009%). This sequence change creates a premature translational stop signal (p.Arg388*) in the RBP3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RBP3 are known to be pathogenic (PMID: 9614228, 23105016, 25766589). |
Center for Genomic Medicine, |
RCV001376320 | SCV004805987 | uncertain significance | Retinitis pigmentosa 66 | 2024-03-25 | criteria provided, single submitter | clinical testing | |
Faculty of Health Sciences, |
RCV001257783 | SCV001434646 | pathogenic | Autosomal recessive retinitis pigmentosa | 2012-10-26 | no assertion criteria provided | literature only |